IL15 and type 2 diabetes mellitus: Despite limitations, this study demonstrates a distinctive inflammatory tear cytokine profile (elevated IL-6, CXCL8, IL-15, CCL5, VEGF) in type 2 diabetes patients, contrasting with decreased systemic inflammation.